Ginkgo bioworks announces inaugural members of new biopharma advisory board

Boston , jan. 8, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new biopharma advisory board. this council of experts from across the biopharmaceutical industry will provide critical insight into the development of ginkgo's core platform service offerings across target discovery, drug discovery, optimization, and manufacturing.
DNA Ratings Summary
DNA Quant Ranking